We wish to also highlight the possible role of heparan sulfate and heparanase in the endothelial dysfunction of COVID‐19, via the heparan sulfate‐heparanase pathway that triggers increased serum levels of inflammatory cytokines as part of disease pathobiology and additional targeted therapies derived thereon. The gene discussed is HPSE; the disease is COVID-19.